Are you looking for expert advice...

As part of our work to support the prescribing of medical cannabis for children living with treatment-resistant epilepsy, the Medical Cannabis Clinicians Society has developed an expert panel to provide multi-disciplinary guidance to anonymised individual cases presented by prescribing UK physicians.

Led by Professor Mike Barnes, Chair of The Medical Cannabis Clinicians Society, the Resistant Epilepsy Cannabis Assessment Panel (RECAP) is made up of national cannabis experts, all members of the Society’s expert committee. It is supported by international paediatric neurologists with specialisation in the treatment of epilepsy.

Purple ribbon for epilepsy

Objectives of the RECAP Panel

  1. Reduce harm by reducing the impact of unguided care. Some patients are using black market products without clinical oversight, and others are directed to surgery before being given the opportunity to consider medical cannabis.
  2. Support doctors with an independent pathway to procure guidance from their peers with global expertise and clinical experience regarding medical cannabis and epilepsy treatments.
  3. Collect real-world evidence through anonymised data regarding medical cannabis treatment to inform future therapeutic benefit and regulatory procedure.

How the Panel works

  1. The Clinician decides a patient may benefit from medical cannabis treatment and begins to explore options
  2. They contact the Society via email to arrange an appointment with RECAP through Zoom.
  3. The Clinician will complete a short form to provide RECAP with the necessary anonymised information about the patient.
  4. RECAP members will review the case independently, then as a team, before meeting with the prescribing Clinician to discuss the case and provide peer support. This meeting will take place within seven working days of the Clinician’s enquiry, wherever possible.

If you are a paediatrician wishing to prescribe medical cannabis for a patient and need support, email [email protected] to arrange.

News

News, case studies, clinician profiles and patient stories from the Medical Cannabis Clinicians Society.

Patient Stories

Patient Stories

Hear from patients benefiting from medical cannabis treatments in the UK.

Join the MCCS

Join the MCCS

Key reasons to join MCCS, a supportive clinical community growing by the day. Exclusive prescribing information, product details and peer support.

Society reaches membership high & embarks on UK event tour in 2022
April 29, 2022

Society reaches membership high & embarks on UK event tour in 2022

Just two and half years after launch, the Medical Cannabis Clinicians Society today reports over 300 members as it prepares to launch a series of in-person events for 2022. Over…

Exploring the barriers to cannabis in children with intractable epilepsy
December 16, 2021

Exploring the barriers to cannabis in children with intractable epilepsy

Virtual roundtable - watch again On 13 December, international paediatric neurologists and medical cannabis experts came together for a panel discussion about the UK's prescribing crisis for children with intractable…

86% seizure reduction in children treated with whole plant medicinal cannabis
December 15, 2021

86% seizure reduction in children treated with whole plant medicinal cannabis

Epileptic seizure frequency fell by an average of 86% among 10 children treated with whole plant medicinal cannabis, reveals research by charity Drug Science and published in BMJ Paediatrics Open. …

Society & Drug Science call for UK paediatricians to recognise the value of medical cannabis for childhood epilepsy – response to latest BPNA guidance
December 3, 2021

Society & Drug Science call for UK paediatricians to recognise the value of medical cannabis for childhood epilepsy – response to latest BPNA guidance

    The BPNA recently produced new guidance on the prescription of cannabis medicines for children with epilepsy. However, the Medical Cannabis Clinicians Society (UKMCCS) and Drug Science fundamentally disagree…